Public Health Agency of Canada
Symbol of the Government of Canada

E-mail this page





Organized Breast Cancer Screening Programs in Canada - Report on Program Performance in 2001 and 2002

 

References

  1. National Cancer Institute of Canada. Canadian Cancer Statistics 2005. Toronto, Canada, 2005.

  2. Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health 1996; 17:47-67.

  3. Health Canada. Summary Report: Review of Lifestyle and Environmental Risk Factors for Breast Cancer. Ottawa: Minister of Public Works and Government Services Canada, 2001; Cat. No. H39-586/2001E.

  4. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA 1995; 273(2):149-54.

  5. World Health Organization: International Agency for Research on Cancer. Handbook for Cancer Prevention, Volume 7, Breast Cancer Screening. IARC Press, 2002.

  6. Baxter N. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer? CMAJ 2001; 164(13):1837-46.

  7. Health Canada. Report from the Evaluation Indicators Working Group: Guidelines for Monitoring Breast Cancer Screening Program Performance. Ottawa: Minister of Public Works and Government Services Canada, 2002.

  8. Adab P,McGhee SM, Yanova J, Wong CM,Hedley AJ. Effectiveness and efficiency of opportunistic cervical cancer screening: comparison with organized screening. Med Care 2004; 42(6):600-9.

  9. Bancej C, Decker K, Chiarelli A, Harrison M, Turner D, Brisson J. Contribution of clinical breast examination to mammography screening in the early detection of breast cancer. J Med Screen 2003; 10(1):16-21. 39

  10. Kan L, Olivotto IA, Warren Burhenne LJ, Sickles EA, Coldman AJ. Standardized abnormal interpretation and cancer detection ratios to assess reading volume and reader performance in a breast screening program. Radiology 2000; 215(2):563-7.

  11. Theberge I, Hebert-Croteau N, Langlois A, Major D, Brisson J. Volume of screening mammography and performance in the Quebec population-based Breast Cancer Screening Program. CMAJ 2005; 172(2):195-9.

  12. Health Canada. Quality Determinants of Organized Breast Cancer Screening Programs in Canada. Ottawa: Minister of Public Works and Government Services Canada, 2003; Cat. No. H39-407/2003E-IN.

  13. Investigation of lesions detected by mammography. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists. CMAJ 1998; 158 Suppl 3:S9-14.

  14. Ugnat AM, Xie L, Morriss J, Semenciw R, Mao Y. Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, history, grade and treatment. British Journal of Cancer 2004;90:1138-1143.

  15. Warren R, Duffy S. Interval cancers as an indicator of performance in breast screening. Breast Cancer 2000; 7(1):9-18.

  16. Olivotto IA, Bancej C, Goel V et al.Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ 2001; 165(3):277-83.

  17. Olivotto IA, Borugian MJ, Kan L et al. Improving the time to diagnosis after an abnormal screening mammogram. Can J Public Health 2001; 92(5):366-71.

  18. Decker KM, Harrison M, Chateau D. Influence of direct referrals on time to diagnosis after an abnormal breast screening result. Cancer Detect Prev 2004; 28(5):361-7.

  19. Psooy BJ, Schreuer D, Borgaonkar J, Caines JS. Patient navigation: improving timeliness in the diagnosis of breast abnormalities. Can Assoc Radiol J 2004; 55(3):145-50. 40

  20. Wait Time Alliance. No more time to wait. Toward benchmarks and best practices in wait-time management. An interim report by the Wait Time Alliance for Timely Access to Health Care. 2005.

  21. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA 2005; 293(10):1245-56.

Previous Page | Table of Contents | Next Page